bullish

ECM Weekly (18 April 2019) - Duiba Group, MabPharm, Huami, Cofco Meat, Innovent, Times China

883 Views18 Apr 2019 17:21
SUMMARY

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.

The short week did little to slow down placements in Hong Kong.

Cofco Meat (1610 HK) and Innovent Biologics Inc (1801 HK) shares were sold by investors in the companies but the two had polarizing post-deal performance. Cofco Meat's share price held up well even after its settlement today on the back of strong pork prices while Innovent Bio's share price broke through deal price on the first day as three sellers came onto the market to sell just as lock-up expire. The eagerness to sell Innovent's shares is probably the reason for its poor performance since there are about US$3.1bn worth of shares unlocked.

As for upcoming IPOs in Hong Kong, Mulsanne Group's IPO has been approved by HKEX and the PHIP has been filed. Sumeet Singh had already analyzed the company earlier in Alpha Smart - Pre-IPO - PE Investors Recovered 56% of Their Cost in Two Years but Left It in Debt. There had also been news reporting that Citi and BAML have been added as advisoers to AB Inbev's Asia IPO. For early thoughts on the company:

In India, Sterling and Wilson has already started its investor education for its IPO. We are probably going to see more filings and IPO launch in India after the decent performance by the two IPOs this week, Metropolis Health Services Limited (METROHL IN) and Polycab India (POLYCAB IN).

In Japan, Japan Post Insurance (7181 JP)'s mega placement had been a disappointment so far partly due to its strong share price rally post-announcement we saw last week. Sumeet Singh had mentioned in his note that the deal has to price at a discount to its undisturbed price to warrant a buy for the placement. Neverthless, there could still be a trade in the Japan Post Holdings (6178 JP) and Japan Post Bank (7182 JP) as explained in Japan Post Holdings and Japan Post Bank - Early Thoughts on a Choice of Two Trades.

Accuracy Rate:

Our overall accuracy rate is 72.4% for IPOs and 64% for Placements

(Performance measurement criteria is explained at the end of the note)

New IPO filings

  • Sterling and Wilson (India, US$600m)
  • Bajaj Energy (India, US$700m)
  • Hutchison China MediTech (Hong Kong, US$500m)

Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.

Source: Aequitas Research, Smartkarma

News on Upcoming IPOs

Analysis on Upcoming IPO

NameInsight
Hong Kong
AB InbevAb InBev Asia Pre-IPO - A Brief History of the Asia Pacific Operations - Eeking Out Growth in China
AscentageAscentage Pharma (亚盛医药) IPO: Too Early for an IPO
Ant FinancialAnt Financial IPO Early Thought: Understand Fintech Empire, Growth & Risk Factors
CIMC VehCIMC Vehicle (中集车辆): Market Leader of Semi-Trailers but Little Growth Ahead
ByteDance

ByteDance (字节跳动) IPO: How Jinri Toutiao Paves The Way for a Bigger Empire (Part 1)

ByteDance

ByteDance (字节跳动) IPO: Tiktok the No.1 Short Video App for a Good Reason (Part 2)

East EduChina East Education (中国东方教育) Pre-IPO - The Company Known for Its Culinary School
China TobacChina Tobacco International (IPO): The Monopolist Will Not Recover
China TobacChina Tobacco Intl (HK) IPO: Proxy For the Chinese Cigarette Consumption
ESRESR Cayman Pre-IPO - A Giant in the Making
ESR

ESR Cayman Pre-IPO - Earnings and Segment Analysis

ESR

ESR Cayman Pre-IPO- First Stab at Valuation

Frontage

Frontage (方达控股) IPO: More Disclosure Needed to Understand Moat and Growth Prospect

Frontage

Frontage (方达控股) IPO: Updates from 2018 Numbers

Hujiang Edu

Hujiang Education (沪江教育) Pre-IPO - Spending More than It Earns

Jinxin

Jinxin Fertility (锦欣生殖) Pre-IPO: Strong Foothold in Sichuan but Weak Sentiment for Sector

MicuRxMicuRx Pharma (盟科医药) IPO: Betting on Single Drug in the Not so Attractive Antibiotic Segment
MabPharmMabPharma (迈博医药) IPO: Assembled for a Trade?
MabPharmMabPharm (迈博医药) IPO: Thoughts on Valuation (Part 2)
SH Henlius

Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio

TubatuTubatu Group Pre-IPO - Performing Better than Qeeka but Growing Much Slower, US$1bn a Stretch
TubatuTubatu Group Pre-IPO - Online -> Online + Offline -> Online -> ?
Viva BioViva Biotech (维亚生物) IPO: When CRO Becomes Early Stage Biotech Investor
Viva BioViva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)
South Korea
KMH ShillaKMH Shilla Leisure IPO Preview (Part 1) - Highly Profitable Operator of Public Golf Courses in Korea
KMH ShillaKMH Shilla Leisure IPO Preview (Part 2) - Valuation Analysis
Plakor

Plakor IPO Preview (Part 1)

ZinusZinus IPO Preview (Part 1) - An Amazing Comeback Story (#1 Mattress Brand on Amazon)
India
Anmol IndAnmol Industries Pre-IPO Quick Take - No Growth, Generous Payments to Founders
Bharat Hotels

Bharat Hotels Pre-IPO - Catching up with Peers

CMS InfoCMS Info Systems Pre-IPO - When a PE Sells to Another PE... Only One Gets the Timing Right
Crystal CropCrystal Crop Protection Pre-IPO - DRHP Raises More Questions than in Answers
Flemingo Flemingo Travel Retail Pre-IPO - Its a Different Business in Every Country
NSENSE IPO Preview- Not Only Fast..its Risky and Expensive
NSENational Stock Exchange Pre-IPO Review - Bigger, Better, Stronger but a Little Too Fast for Some
MazagonMazagon Dock IPO Preview: A Monopoly Submarine Yard in India with Captive Navy Spending
Mrs. BectorMrs. Bectors Food Specialities Pre-IPO Quick Take - Sales for Its Main Segment Have Been Sta

Lodha

Lodha Developers Pre-IPO - Second Time Lucky but Not Really that Much Affordable
LodhaLodha Developers IPO: Presence in Affordable Segment Saves Lodha the Blushes in a Sluggish Mkt
IndiaMartIndiaMART Pre-IPO - Getting and Retaining Subscribers Seems to Be Difficult
PNB MetPNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers
Malaysia
QSRQSR Brands Pre-IPO - As Healthy as Fast Food
LeongHupLeong Hup Pre-IPO - Hard to Pinpoint What's Going to Be the Revenue Driver Going Forward
The U.S
YunjiYunji (云集) Pre-IPO Review - Poor Disclosure on Data
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
x